SCHEMBL7218006

SCHEMBL7218006

COc1ccc2nc3[nH]cnc(Cl)c-3c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.48
KDM4E B2RXH2 7/20 0.43
HSD17B10 Q99714 3/20 0.43
LMNA P02545 2/20 0.43
ALDH1A1 P00352 3/20 0.42
HPGD P15428 2/20 0.42
TSHR P16473 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42
NFKB1 P19838 1/20 0.42
RAB9A P51151 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
MAPT P10636 2/20 0.40
POLB P06746 2/20 0.40
SLC2A1 P11166 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12285138 0.70 KDM4E (0.55) KDM4EHSD17B10LMNAALDH1A1HPGD
SCHEMBL16416223 0.70 KDM4E (0.46) MMP12KDM4EHSD17B10LMNAALDH1A1
SCHEMBL857818 0.69 KDM4E (0.48) KDM4EHSD17B10LMNAALDH1A1HPGD
SCHEMBL29532068 0.69 KDM4E (0.48) KDM4EHSD17B10LMNAALDH1A1HPGD
SCHEMBL1257525 0.68 KDM4E (0.50) KDM4EHSD17B10LMNAALDH1A1HPGD
Hydrochloric Acid SCHEMBL28031937 0.68 BCHE (0.48) KDM4EHSD17B10LMNAALDH1A1HPGD
SCHEMBL1257333 0.67 PARP1 (0.63) MMP12KDM4EHSD17B10LMNAALDH1A1
SCHEMBL29420513 0.66 SMN1; SMN2 (0.48) KDM4EHSD17B10LMNAALDH1A1HPGD
SCHEMBL830265 0.66 SMN1; SMN2 (0.48) KDM4EHSD17B10LMNAALDH1A1HPGD
SCHEMBL591893 0.66 MAPT (0.56) KDM4ELMNAALDH1A1HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596726-B1 Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme WARNER LAMBERT COMPANY 2003-07-22 US disclosed
EP-0741711-A1 TRICYCLIC COMPOUNDS CAPABLE OF INHIBITING TYROSINE KINASES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR FAMILY WARNER-LAMBERT COMPANY (US) 1996-11-13 EP disclosed
WO-1995019970-A1 TRICYCLIC COMPOUNDS CAPABLE OF INHIBITING TYROSINE KINASES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR FAMILY WARNER-LAMBERT COMPANY (US) 1995-07-27 WO disclosed